Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia.
暂无分享,去创建一个
B. Pitel | N. Hoppman | D. Wolff | C. Schandl | J. Morse | L. Baughn | Kathryn E. Pearce | Kathryn G Lindsey | Iya Y Znoyko | Jessica S Snider
[1] M. Slovak,et al. Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group. , 2018, Cancer genetics.
[2] A. Bagg,et al. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study , 2018, Modern Pathology.
[3] M. Slovak,et al. Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative n , 2018, Cancer genetics.
[4] Travis M. Drucker,et al. Copy number variant analysis using genome‐wide mate‐pair sequencing , 2018, Genes, chromosomes & cancer.
[5] Travis M. Drucker,et al. SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq). , 2018, Cancer genetics.
[6] A. Reiter,et al. Myeloid neoplasms with eosinophilia. , 2017, Blood.
[7] Travis M. Drucker,et al. BIMA V3: an aligner customized for mate pair library sequencing , 2014, Bioinform..
[8] Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2 , 2020, Definitions.